Un panel de la FDA respalda a un controversial fármaco para la ELA en su segunda revisión, un paso raro
JUEVES, 8 de septiembre de 2022 (HealthDay News) — El miércoles, un panel de la Administración de Alimentos y Medicamentos (FDA) de EE. UU. recomendó la aprobación de un medicamento experimental para la ELA (esclerosis lateral amiotrófica) en una seg…
Learn MoreNovel Bihormonal Artificial Pancreas Beneficial After Pancreatectomy
FRIDAY, Sept. 9, 2022 (HealthDay News) — Patients after total pancreatectomy receiving a novel, fully closed-loop bihormonal artificial pancreas (BIHAP) using both insulin and glucagon, experience significantly more time spent in euglycemia than thos…
Learn MoreUna prueba sanguínea se muestra promisoria para un diagnóstico rápido de la ELA
MIÉRCOLES, 7 de septiembre de 2022 (HealthDay News) — Los pacientes con sospecha de esclerosis lateral amiotrófica (ELA) quizá puedan pronto recibir un diagnóstico con mucha más rapidez, y no desperdiciar el valioso tiempo que les queda, sugiere una …
Learn MoreIn Rare Move, FDA Panel Gives Support to Controversial ALS Drug in 2nd Review
THURSDAY, Sept. 8, 2022 (HealthDay News) – In a rare second review, a U.S. Food and Drug Administration panel on Wednesday recommended approval for an experimental drug for ALS (amyotrophic lateral sclerosis). The FDA is not obligated to follow its ad…
Learn MoreUn panel de la FDA se muestra escéptico sobre un controversial fármaco para la ELA antes de una votación
MARTES, 6 de septiembre de 2022 (HealthDay News) — Un panel de la Administración de Alimentos y Medicamentos (FDA) de EE. UU. sopesará de nuevo la aprobación de un medicamento experimental para la ELA, una segunda revisión poco común, para una enferm…
Learn MoreJustin Bieber Takes Break From Touring Due to Health Issues
WEDNESDAY, Sept. 7, 2022 (HealthDay News) — Singer Justin Bieber said Tuesday that he will take a break from touring while he takes care of his health. Bieber has a condition known as Ramsay Hunt syndrome, which is rare type of viral infection. Cause…
Learn MoreBlood Test Shows Promise for Quick Diagnosis of ALS
WEDNESDAY, Sept. 7, 2022 (HealthDay News) — Patients suspected of having amyotrophic lateral sclerosis (ALS) may soon be able to get a diagnosis much more quickly, not wasting the precious time many have left, new research suggests.In 2020, a blood t…
Learn MoreWith ‘Chemical Imbalance’ Theory in Doubt, What’s Next for Depression Care?
TUESDAY, Sept. 6, 2022 (HealthDay Now) — For Mary Christ, the idea that depression is a chemical imbalance in the brain has always felt true to her personal experience.A former educator, Christ, 57, has taken antidepressants for much of her adult li…
Learn MoreFDA Panel Skeptical of Controversial ALS Drug Ahead of Vote
TUESDAY, Sept. 6, 2022 (HealthDay News) – A U.S. Food and Drug Administration panel will once again consider approval for an experimental drug for ALS, a rare second review for a disease that has no cure. The same panel that will meet Wednesday voted …
Learn MoreCómo ‘This Is Us’ enfocó la atención en los cuidados para el Alzheimer
JUEVES, 1 de septiembre de 2022 (HealthDay News) — Cuando el inmensamente popular programa de televisión “This Is Us” emitió su última temporada este año, lo hizo con una trama que mostraba a uno de los personajes principales afrontando la enfermedad…
Learn More